BioMarin Pharmaceutical Inc. (BMRN) CEO Jean-Jacques Bienaimé on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Seeking Alpha
BioMarin Pharmaceutical Inc. (NASDAQ:BMRNCompany ParticipantsTraci McCarty - Vice President, Investor RelationsJean-Jacques Bienaimé - Chairman and Chief Executive OfficerRobert Baffi - President of Global Manufacturing and Technical OperationsJeff Ajer - Executive Vice President and Chief Commercial OfficerHenry Fuchs - President, Worldwide Research and DevelopmentBrian Mueller - Acting Chief Financial OfficerConference Call ParticipantsRobyn Karnauskas - SunTrust Robinson Humphrey IncSalveen Richter - Goldman SachsJoshua Schimmer - Evercore ISICory Kasimov - JPMorganGeoffrey Meacham - Bank of America Merrill LynchAkash Tewari - Wolfe Research, LLCChristopher Raymond - Piper SandlerPhilip Nadeau - Cowen and CompanyMatthew Harrison - Morgan StanleyAlex Thompson - Stifel NicolausMohit Bansal - CitigroupTim Lugo - William Blair & Company, L.L.C.Kennen MacKay - RBC Capital Peter Kim - Barclays CapitalEliana Merle - Cantor FitzgeraldVincent Chen - Bernstein ResearchOperatorWelcome to the
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (NASDAQ:BMRN) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $60.00 price target on the stock, down previously from $82.00.MarketBeat
- BioMarin Pharmaceutical (BMRN): Evaluating Valuation After Raised Guidance on Revenue Strength [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (NASDAQ:BMRN) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- 2 Reasons to Like BMRN and 1 to Stay Skeptical [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/2/25 - Form 4
- 11/14/25 - Form SCHEDULE
- 10/28/25 - Form 10-Q
- BMRN's page on the SEC website